VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.18−0.01 (-3.02%)
Close on Nov 18, 2026Market cap $2.50MP/E –Yield –
VolitionRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
VolitionRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.56M. For fiscal 2025 it was -$19.68M. The highest annual figure on record is -$1.65M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.68M | – |
| FY2024 | Dec 31, 2024 | -$25.89M | – |
| FY2023 | Dec 31, 2023 | -$18.06M | – |
| FY2022 | Dec 31, 2022 | -$15.28M | – |
| FY2021 | Dec 31, 2021 | -$20.85M | – |
| FY2020 | Dec 31, 2020 | -$16.46M | – |
| FY2019 | Dec 31, 2019 | -$12.74M | – |
| FY2018 | Dec 31, 2018 | -$14.73M | – |
| FY2017 | Dec 31, 2017 | -$12.19M | – |
| FY2016 | Dec 31, 2016 | -$8.86M | – |
| FY2015 | Dec 31, 2015 | -$8.55M | – |
| FY2014 | Dec 31, 2014 | -$4.14M | – |
| FY2013 | Dec 31, 2013 | -$3.08M | – |
| FY2012 | Dec 31, 2012 | -$2.31M | – |
| FY2011 | Dec 31, 2011 | -$1.65M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.28M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.49M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.63M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.30M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.43M | -184.2% |
| Q3 FY2024 | Sep 30, 2024 | -$5.39M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.73M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.34M | – |
| Q4 FY2023 | Dec 31, 2023 | $6.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.42M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.35M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.74M | -342.2% |
| Q4 FY2022 | Dec 31, 2022 | -$5.80M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.82M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.27M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.61M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.41M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.17M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.73M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.50M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.43M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.80M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.60M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.72M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.77M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.65M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.63M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.61M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.98M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.51M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.89M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.82M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.81M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.67M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.19M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.11M | – |
See a number that looks wrong?